Abstract
Isolated GH deficiency or combined pituitary hormone deficiencies have been associated with mutations in transcription factors encoding genes that control organogenesis or cell differentiation. Among these factors, Hesx1 is essential for the development of the optic nerve and regulates some of the earliest stages in pituitary development and is intimately involved in orchestrating the expression of other factors involved in pituitary organogenesis. Mutations in HESX1 are reported in patients with hypopituitarism either with typical septo-optic dysplasia (SOD) or with neuromorphological abnormalities not included in classical SOD. The present report describes clinical features, biochemical parameters, and characterization of a missense mutation (Gln6His) in exon1 of HESX1 in a pre-pubertal child who progressively developed multiple hypopituitarism, firstly GH and, afterwards, TSH and ACTH deficiencies, in a pluri-malformative syndrome characterized by short stature and anatomical malformations not associated with a classical SOD phenotype. This finding further supports the necessity to stay alert in evaluating a gene that plays a minor role in the pathogenesis of sporadic hypopituitarism, such as HESX1 gene even when the phenotype does not fit in with a classical SOD syndrome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rosenfeld MG, Briata P, Dasen J, et al. Multipstep signaling and transcriptional requirements for pituitary organogenesis in vivo. Recent Prog Horm Res 2000, 55: 1–14.
Cohen LE, Radovick S. Molecular basis of combined pituitary hormone deficiencies. End Rev 2002, 23: 431–42.
Hermesz E, Mackem S, Mahon KA. Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke’s pouch of the mouse embryo. Development 1996, 122: 41–52.
Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 1996, 10: 1570–81.
Martinez-Barbera JP, Rodriguez TA, Beddington RS. The homeobox gene Hesx1 is required in the anterior neural forebrain formation. Dev Biol 2000, 223: 422–30.
Dattani MT, Robinson IC. HESX1 and Septo-Optic Dysplasia. Rev Endocr Metab Disord 2002, 3: 289–300.
Dattani MT, Martinez-Barbera JP, Thomas PQ, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998, 19: 125–33.
Sobrier ML, Netchine I, Heinrichs C, et al. Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum Mutat 2005, 25: 503.
Sobrier ML, Maghnie M, Vié-Luton MP, et al. Novel HESX1 mutations associated with a life-threatening neonatal phenotype, pituitary aplasia, but normally located posterior pituitary and no optic nerve abnormalities. J Clin Endocrinol Metab 2006, 91: 4528–36.
Melo ME, Marui S, Carvalho LR, et al. Hormonal, pituitary magnetic resonance, LHX4 and HESX1 evaluation in patients with hypopituitarism and ectopic posterior pituitary lobe. Clin Endocrinol (Oxf) 2007, 66: 95–102.
Carvalho LR, Woods KS, Mendonca BB, et al. A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. J Clin Invest 2003, 112: 1192–201.
Thomas PQ, Dattani MT, Brickman JM, et al. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Hum Mol Gen 2001, 10: 39–45.
Tajima T, Hattorri T, Nakajima T, et al. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. J Clin Endocrinol Metab 2003, 88: 45–50.
Cohen RN, Cohen LE, Botero D, et al. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003, 88: 4832–9.
Coya R, Vela A, Pérez de Nanclares G, et al; GEDPIT group. Panhypopituitarism: genetic versus acquired etiological factors. J Pediatr Endocrinol Metab 2007, 20: 27–36.
McNay DE, Turton JP, Kelberman D, et al. HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarism. J Clin Endocrinol Metab 2007, 92: 691–7.
Ranke MB, Haber P. Growth hormone stimulation tests. In Functional Endocrinologic Diagnostics in Children and Adolescents, edn 1, pp 61–75. Ed. Ranke MB, J&J Verlag: Mannheim, 1992.
Miller SA, Dykes DD, Polesky HF. A simple salting-out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16: 1215.
Brucker-Davis F, Pointis G, Chevallier D, Fenichel P. Update on cryptorchidism: endocrine, environmental and therapeutic aspects. J Endocrinol Invest 2003, 26: 575–87.
Brickman JM, Clements M, Tyrell R, et al. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development 2001, 128: 5189–99.
Smith ST, Jaynes JB. A conserved region of engrailed, shared among all en-, gsc-, Nk1 -, Nk2- and msh-class homeoproteins, mediates active transcriptional repression in vivo. Development 1996, 122: 3141–50.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corneli, G., Vivenza, D., Prodam, F. et al. Heterozygous mutation of HESX1 causing hypopituitarism and multiple anatomical malformations without features of septo-optic dysplasia. J Endocrinol Invest 31, 689–693 (2008). https://doi.org/10.1007/BF03346416
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03346416